https://g.co/finance/SAKAR:NSE
Introduction
Sakar Healthcare Limited was established in 2004. It is an Indian pharmaceutical company. The company specializes in the development, manufacturing, and marketing of a wide range of pharmaceutical formulations. The company’s product portfolio includes tablets, capsules, liquid orals, dry syrups, and injectables, catering to various therapeutic segments. Over the years, Sakar Healthcare has made significant strides in both domestic and international markets. The company has established itself as a reputable player in the healthcare industry.
Current Share Price and Performance
As of March 12, 2025, Sakar Healthcare’s share price stands at ₹255.65, reflecting a slight increase of 0.22% from the previous close of ₹255.09.
economictimes.indiatimes.com The stock has experienced fluctuations over the past year, with a 52-week high of ₹385.00 and a low of ₹213.20.
Recent Performance Metrics
- 1 Week: The share price decreased by 7.51%.
- 1 Month: A decline of 3.46% was observed.
- 3 Months: The stock saw a decrease of 25.17%.
- 6 Months: A significant drop of 28.58% occurred.
Shareholding Pattern
As of December 31, 2024, the shareholding pattern of Sakar Healthcare is as follows:
- Promoters: 53.58%
- Domestic Institutional Investors (DII): 10.88%
- Foreign Institutional Investors (FII): 13.57%
- Others: 21.97%
Notably, promoter holdings have increased from 53.15% in September 2024 to 53.58% in December 2024, indicating a positive outlook from the promoters.
Financial Highlights
Sakar Healthcare has maintained profitability over the years; however, certain financial metrics warrant attention:
- Return on Equity (ROE): The company has a low ROE of 8.18% over the last three years. Screener
- Dividend Policy: Despite consistent profits, the company has not declared dividends, which might concern income-focused investors.
- Working Capital: There has been an increase in working capital days from 31.4 to 62.0, suggesting potential inefficiencies in operational management.
Market Capitalization
The current market capitalization of Sakar Healthcare is approximately ₹524 crore.
moneycontrol.com This valuation positions the company within the small-cap segment of the Indian stock market.
Analyst Perspectives
Analysts have mixed views on Sakar Healthcare’s stock:
- Pros:
- Consistent profitability over the years.
- Increasing promoter stake, reflecting confidence in the company’s prospects.
- Cons:
- Low return on equity, indicating suboptimal utilization of shareholders’ funds.
- Absence of dividend payouts, which might deter income-seeking investors.
- Rising working capital days, pointing towards potential operational inefficiencies.
Conclusion
Sakar Healthcare Limited has established a solid foundation in the pharmaceutical industry. It offers a diverse product portfolio. The company also enjoys a growing market presence. However, investors should carefully consider the company’s financial metrics. These include return on equity, dividend policy, and working capital management. Investors should evaluate these metrics before making investment decisions. The recent increase in promoter holdings is a positive sign. However, potential investors should conduct thorough due diligence. They should consult financial advisors to align their investment choices with their financial goals and risk tolerance.
Disclaimer: This article is for informational purposes only and does not constitute financial advice. Investing in the stock market involves risks. Readers are advised to conduct their own research or consult with a qualified financial advisor before making any investment decisions.
Sources
